13.15
price down icon2.45%   -0.33
after-market Dopo l'orario di chiusura: 13.15
loading

Entrada Therapeutics Inc Azioni (TRDA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
19.52%
1.299
1.614 1.95 20.56 19.57
Operating Expenses
10.60%
43.51
48.66 48.80 42.35 41.23
Benefits Costs and Expenses
-
- - 37.91 -
Costs And Expenses
10.60%
43.51
48.66 48.80 37.91 41.23
Operating Income/Loss
10.29%
-42.21
-47.05 -46.85 -21.79 -21.66
Income/Loss From Continuing Operations Before Tax
19.52%
1.299
1.614 -43.10 -17.35 19.57
Income Tax Expense/Benefit
85.93%
0.092
0.654 0.178 - -1.86
Income/Loss From Continuing Operations After Tax
11.26%
-39.16
-44.13 -43.10 -17.35 -14.03
Net Income/Loss
11.26%
-39.16
-44.13 -43.10 -17.35 -14.03
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.81%
0.0784
41.46 41.34 41.07 40.63
Diluted Average Shares
99.81%
0.0784
41.46 41.34 41.07 40.63
Basic Earnings Per Share
11.32%
-0.94
-1.06 -1.04 -0.42 -0.35
Diluted Earnings Per Share
11.32%
-0.94
-1.06 -1.04 -0.42 -0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$99.12
price up icon 0.49%
$28.33
price up icon 1.76%
$48.57
price up icon 0.16%
$91.18
price up icon 1.97%
ONC ONC
$310.79
price up icon 0.76%
$162.43
price down icon 1.47%
Capitalizzazione:     |  Volume (24 ore):